表紙
市場調査レポート

中国の乳癌治療薬市場

Breast Cancer Treatment Drug Markets in China

発行 Asia Market Information & Development 商品コード 81745
出版日 ページ情報 英文 256 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
中国の乳癌治療薬市場 Breast Cancer Treatment Drug Markets in China
出版日: 2016年03月18日 ページ情報: 英文 256 Pages
概要

中国における乳癌治療薬の需要は過去10年間急速に拡大しています。今後の5年間においても生産、需要ともに順調に増加し続ける見通しです。

当レポートでは、中国の経済動向、投資環境、産業の発展、需要および供給、産業構造、市場チャネルおよび主要企業などについて詳細に調査し、過去の実績と長期予測など、概略以下の構成でお届けします。

第1章 イントロダクション

  • 本調査書の範囲と方法論
  • エグゼクティブサマリー

第2章 ビジネス環境

  • 経済展望
    • 主な経済指標
    • 工業生産量
    • 人口および労働力
    • 海外からの投資
    • 海外貿易
  • 金融および税金の規制
    • 銀行制度および規制
    • 外国為替
    • 税金、関税および税関

第3章 乳癌治療薬産業アセスメント

  • 産業構造
  • 市場規模
  • 市場成長促進要因
  • 販売量
  • 主要メーカーの設備拠点
  • 主なメーカーの販売量および市場シェア
  • 労働コスト
  • 潜在性のある参入企業
  • 主な流通業者
  • 主な海外からの投資
  • 技術開発

第4章 乳癌治療薬の生産および需要

  • 概要
  • 販売量
    • 化学療法剤
    • パクリタキセル
    • フルオロピリミジン
    • アントラサイクリン系抗生物質
    • 標的治療薬
    • 治療抗体
    • 小分子薬
    • アロマターゼ阻害薬(標的治療薬)
    • 内分泌腺治療薬
    • 抗エストロゲン
    • プロゲステロン
    • アロマターゼ阻害薬(内分泌腺治療薬)
    • LH-RH
  • 輸入
    • 化学療法剤
    • パクリタキセル
    • フルオロピリミジン
    • アントラサイクリン系抗生物質
    • 標的治療薬
    • 治療抗体
    • 小分子薬
    • アロマターゼ阻害薬(標的治療薬)
    • 内分泌腺治療薬
    • 抗エストロゲン
    • プロゲステロン
    • アロマターゼ阻害薬(内分泌腺治療薬)
    • LH-RH
  • 価格動向

第5章 乳癌治療薬市場の展望

  • 乳癌治療薬市場の展望
  • 政府の規制
  • 健康保険産業の概要
  • 消費者支出動向
  • 人口動態
  • ヘルスケア産業の動向
  • 病院および病床
  • 医師および往診

第6章 市場参入チャネル

  • 中国市場参入の概要
    • 中国流通システム
    • 流通チャネル
    • 運輸および輸送インフラ
    • 通信
  • 中国市場参入
    • 対中国輸出
    • 間接輸出
    • 直接輸出
    • ライセンスおよび提携製造
    • 中国内の組み立て
    • 提携製造
    • 貿易許可
    • 投資
    • 資本提携
    • 合併企業
    • 完全外資企業

第7章 乳癌治療薬メーカーのディレクトリー

  • メーカーのプロファイルおよびディレクトリー
  • 主なエンドユーザー

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 822

China's demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2005, 2010 and 2015) and long-term forecasts through 2020 and 2025 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Industry Structure
  • Market Size
  • Market Growth Driver
  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Overview
  • Breast Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Progesterone
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drug Markets Outlook Overview Concrete Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Breast Cancer Treatment Drug Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY

  • Breast Cancer Treatment Drug Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BREAST CANCER TREATMENT DRUG INDUSTRY ASSESSMENTS

  • Breast Cancer Treatment Drug Sales Volume
  • Major Producer Facility Locations
  • Major Breast Cancer Treatment Drug Producer Sales Volume and Market Share
  • Major Foreign Investments

IV. BREAST CANCER TREATMENT DRUG PRODUCTION AND DEMAND

  • Total Breast Cancer Treatment Drugs Sales Volume
  • Breast Cancer Treatment Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Progesterone Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Breast Cancer Treatment Drugs Import

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Breast Cancer Treatment Drug Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Breast Cancer Treatment Drug Sales Volume

IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND

  • Breast Cancer Treatment Drug Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Breast Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

V. BREAST CANCER TREATMENT DRUG MARKET OUTLOOK

  • Breast Cancer Treatment Drugs Demand by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top